Cited by 253Advanced Glycation End Products researchReceptor Mechanisms and SignalingProtein Structure and Dynamics

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)

Open access

Xie, Jingjing, Reverdatto, Sergey, Frolov, Andrej, Hoffmann, Ralf, Burz, David S., Shekhtman, Alexander·2008·Journal of Biological Chemistry

DOI 10.1074/jbc.m801622200

Open this paper in CoChat — free account Open PDF

Abstract

The receptor for advanced glycated end products (RAGE) is a multiligand receptor that is implicated in the pathogenesis of various diseases, including diabetic complications, neurodegenerative disorders, and inflammatory responses. The ability of RAGE to recognize advanced glycated end products (AGEs) formed by nonenzymatic glycoxidation of cellular proteins places RAGE in the category of pattern recognition receptors. The structural mechanism of AGE recognition was an enigma due to the diversity of chemical structures found in AGE-modified proteins. Here, using NMR spectroscopy we showed that the immunoglobulin V-type domain of RAGE is responsible for recognizing various classes of AGEs. Three distinct surfaces of the V domain were identified to mediate AGE-V domain interactions. They are located in the positively charged areas of the V domain. The first interaction surface consists of strand C and loop CC ', the second interaction surface consists of strand C ', strand F, and loop FG, and the third interaction surface consists of strand A ' and loop EF. The secondary structure elements of the interaction surfaces exhibit significant flexibility on the ms-micros time scale. Despite highly specific AGE-V domain interactions, the binding affinity of AGEs for an isolated V domain is low, approximately 10 microm. Using in-cell fluorescence resonance energy transfer we show that RAGE is a constitutive oligomer on the plasma membrane. We propose that constitutive oligomerization of RAGE is responsible for recognizing patterns of AGE-modified proteins with affinities less than 100 nm.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.m801622200

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Principles of Fluorescence Spectroscopy
Lakowicz, J. R. (1999) · Springer eBooks · doi:10.1007/978-1-4757-3061-6 · Cited by 26,948
Principles of Fluorescence Spectroscopy
Lakowicz, J. R. (2006) · Springer eBooks · doi:10.1007/978-0-387-46312-4 · Cited by 19,795
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · Electrophoresis · doi:10.1002/elps.1150181505 · Cited by 11,312
AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
The principles of nuclear magnetism
Abragam, A. (1961) · Nuclear Physics · doi:10.1016/0029-5582(61)91110-5 · Cited by 4,056
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
Partitioning of Lipid-Modified Monomeric GFPs into Membrane Microdomains of Live Cells
Zacharias, D. A., Violin, J. D., Newton, A. C., & Tsien, R. Y. (2002) · Science · doi:10.1126/science.1068539 · Cited by 2,270
The 13C Chemical-Shift Index: A simple method for the identification of protein secondary structure using 13C chemical-shift data
Wishart, D. S., & Sykes, B. D. (1994) · Journal of Biomolecular NMR · doi:10.1007/bf00175245 · Cited by 2,174
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864

Show all 81 references

Research works printed but not linked: 4

Schmidt, 2001, Front Biosci., 6, 1151
Thornalley, 1999, Clin. Lab., 45, 263
Lin, 2006, Cell. Mol. Immunol., 3, 351
Thornalley, 1998, Cell. Mol. Biol. (Noisy-le-Grand), 44, 1013

Sorted by citations

Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Advanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751
S100B's double life: Intracellular regulator and extracellular signal
Donato, R., Sorci, G., Riuzzi, F., Arcuri, C., Bianchi, R., Brozzi, F., Tubaro, C., & Giambanco, I. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.009 · Cited by 747
RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
Sparvero, L. J., Asafu-Adjei, D. A., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A. A., Zeh, H. J., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-17 · Cited by 643
Binding of S100 proteins to RAGE: An update
Leclerc, E., Fritz, G., Vetter, S. W., & Heizmann, C. W. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.016 · Cited by 509
RAGE regulation and signaling in inflammation and beyond
Kierdorf, K., & Fritz, G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012519 · Cited by 451
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Stirban, A. O., Gawlowski, T., & Roden, M. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 375
Role of advanced glycation end products in cardiovascular disease
Hegab, Z. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i4.90 · Cited by 361
RAGE: a single receptor fits multiple ligands
Fritz, G. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.08.008 · Cited by 352
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Bongarzone, S., Savickas, V., Luzi, F., & Gee, A. D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00058 · Cited by 313
RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0409230 · Cited by 283
Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review
Zhou, M., Zhang, Y., Shi, L., Li, L., Zhang, D., Gong, Z., & Wu, Q. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107282 · Cited by 286
Structural Basis for Ligand Recognition and Activation of RAGE
Koch, M., Chitayat, S., Dattilo, B. M., Schiefner, A., Diez, J., Chazin, W., & Fritz, G. (2010) · Structure · doi:10.1016/j.str.2010.05.017 · Cited by 251
Pathophysiology of RAGE in inflammatory diseases
Dong, H., Zhang, Y., Huang, Y., & Deng, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931473 · Cited by 268
S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release
Bianchi, R., Kastrisianaki, E., Giambanco, I., & Donato, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169342 · Cited by 246
Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory response
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0439-2 · Cited by 236
Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells
He, M. T., Kubo, H., Morimoto, K., Fujino, N., Suzuki, T., Takahasi, T., Yamada, M., Yamaya, M., Maekawa, T., Yamamoto, Y., et al. (2011) · EMBO Reports · doi:10.1038/embor.2011.28 · Cited by 232
RAGE in tissue homeostasis, repair and regeneration
Sorci, G., Riuzzi, F., Giambanco, I., & Donato, R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.021 · Cited by 237
All the “RAGE” in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses
Oczypok, E. A., Perkins, T. N., & Oury, T. D. (2017) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2017.03.012 · Cited by 229
Advanced glycation end‐products and the kidney
Busch, M., Franke, S., Rüster, C., & Wolf, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02317.x · Cited by 228
Dietary advanced glycation end‐products: Perspectives linking food processing with health implications
Zhang, Q., Wang, Y., & Fu, L. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12593 · Cited by 239
S100B Protein, a Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond
Sorci, G., Bianchi, R., Riuzzi, F., Tubaro, C., Arcuri, C., Giambanco, I., & Donato, R. (2010) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2010/656481 · Cited by 230
Advanced Glycation End Product Recognition by the Receptor for AGEs
Xue, J., Rai, V., Singer, D. L., Chabierski, S., Xie, J., Reverdatto, S., Burz, D. S., Schmidt, A. M., Hoffmann, R., & Shekhtman, A. G. (2011) · Structure · doi:10.1016/j.str.2011.02.013 · Cited by 218
Self-citation
The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction
Sergi, D., Boulestin, H., Campbell, F. M., & Williams, L. M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900934 · Cited by 194
The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs
Xue, J., Ray, R., Singer, D., Böhme, D., Burz, D. S., Rai, V., Hoffmann, R., & Shekhtman, A. (2014) · Biochemistry · doi:10.1021/bi500046t · Cited by 186
Self-citation
Diabetes Mellitus and Cardiovascular Disease
Schmidt, A. M. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.310961 · Cited by 195
RAGE: a novel biological and genetic marker for vascular disease
Kalea, A. Z., Schmidt, A. M., & Hudson, B. I. (2009) · Clinical Science · doi:10.1042/cs20080494 · Cited by 184
Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity
Frevert, C. W., Felgenhauer, J. L., Wygrecka, M., Nastase, M. V., & Schaefer, L. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417740880 · Cited by 190
The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging
Teissier, T., & Boulanger, É. (2019) · Biogerontology · doi:10.1007/s10522-019-09808-3 · Cited by 187
Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.013 · Cited by 169
Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity
Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835aea13 · Cited by 166
Advanced glycation endproducts: from precursors to RAGE: round and round we go
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2010) · Amino Acids · doi:10.1007/s00726-010-0773-2 · Cited by 158
Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases
Kandarakis, S., Piperi, C., Topouzis, F., & Papavassiliou, A. G. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.05.002 · Cited by 167
Effect of diet-derived advanced glycation end products on inflammation
Kellow, N. J., & Coughlan, M. T. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv030 · Cited by 160
The Receptor for Advanced Glycation End-Products (RAGE) Is Only Present in Mammals, and Belongs to a Family of Cell Adhesion Molecules (CAMs)
Sessa, L., Gatti, E., Zeni, F., Antonelli, A., Catucci, A., Koch, M., Pompilio, G., Fritz, G., Raucci, A., & Bianchi, M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086903 · Cited by 153
The 1.5 Å Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding
Park, H., & Boyington, J. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169276 · Cited by 158
Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease
Lai, S. W. T., Gonzalez, E. D. J. L., Zoukari, T., Ki, P., & Shuck, S. C. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00160 · Cited by 154
Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications
Boyapati, R. K., Rossi, A. G., Satsangi, J., & Ho, G. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.14 · Cited by 150
Fueling inflammation at tumor microenvironment: the role of multiligand/rage axis
Armando Rojas, R., Figueroa, H., & Morales, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp322 · Cited by 147
An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and inhibition
Uceda, A. B., Mariño, L., Casasnovas, R., & Adrover, M. (2024) · Biophysical Reviews · doi:10.1007/s12551-024-01188-4 · Cited by 171
Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands
Rao, N. V., Argyle, B., Xu, X., Reynolds, P. R., Walenga, J. M., Prechel, M., Prestwich, G. D., MacArthur, R. B., Walters, B. B., Hoidal, J. R., et al. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00009.2010 · Cited by 144
Reactive Metabolites and AGE/RAGE-Mediated Cellular Dysfunction Affect the Aging Process – A Mini-Review
Fleming, T. H., Humpert, P. M., Nawroth, P. P., & Bierhaus, A. (2010) · Gerontology · doi:10.1159/000322087 · Cited by 139
Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics
Schalkwijk, C. G., & Miyata, T. (2010) · Amino Acids · doi:10.1007/s00726-010-0779-9 · Cited by 135
Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction
Zong, H., Madden, A. F., Ward, M. S., Mooney, M. H., Elliott, C. T., & Stitt, A. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133827 · Cited by 134
Signal Transduction in Receptor for Advanced Glycation End Products (RAGE)
Rai, V., Maldonado, A. Y., Burz, D. S., Reverdatto, S., Schmidt, A. M., & Shekhtman, A. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277731 · Cited by 126
Self-citation
Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function
Moroz, O. V., Burkitt, W., Wittkowski, H., He, W., Ianoul, A. I., Novitskaya, V., Xie, J., Polyakova, O., Lednev, I. K., Shekhtman, A. G., et al. (2009) · BMC Biochemistry · doi:10.1186/1471-2091-10-11 · Cited by 122
Self-citation
RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration
Gąsiorowski, K., Brokos, B., Echeverrı́a, V., Barreto, G. E., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0419-4 · Cited by 120
RAGE-Mediated Cell Signaling
Rouhiainen, A., Kuja‐Panula, J., Tumova, S., & Rauvala, H. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-230-8_15 · Cited by 118
Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Biomarker of Emphysema and the RAGE Axis in the Lung
Yonchuk, J. G., Silverman, E. K., Bowler, R. P., Agustí, A. G. N., Lomas, D. A., Miller, B. E., Tal‐Singer, R., & Mayer, R. J. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0137pp · Cited by 111
Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease
Reynaert, N. L., Gopal, P., Rutten, E. P. A., Wouters, E. F. �., & Schalkwijk, C. G. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.016 · Cited by 113
Comparison of Free and Bound Advanced Glycation End Products in Food: A Review on the Possible Influence on Human Health
Zhao, D., Sheng, B., Wu, Y., Li, H., Xu, D., Nian, Y., Mao, S., Li, C., Xu, X., & Zhou, G. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05891 · Cited by 107
Clinical/Translational Aspects of Advanced Glycation End-Products
Zeng, C., Li, Y., Ma, J., Niu, L., & Tay, F. R. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.08.005 · Cited by 107
APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner
Cui, S., Xiong, F., Hong, Y., Jung, J.-U., Li, X.-S., Liu, J.-Z., Yan, R., Mei, L., Feng, X., & Xiong, W.-C. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.299 · Cited by 101
“Human Ab (1-42) (from AnaSpec, Fremont, CA, USA) was used.”
Method
Plasma-Advanced Oxidation Protein Products Are Potent High-Density Lipoprotein Receptor Antagonists In Vivo
Marsche, G., Frank, S., Hrzenjak, A., Holzer, M., Dirnberger, S., Wadsack, C., Scharnagl, H., Stojaković, T., Heinemann, Á., & Oettl, K. (2009) · Circulation Research · doi:10.1161/circresaha.108.193169 · Cited by 98
RAGE: a new frontier in chronic airways disease
Sukkar, M. B., Ullah, M. A., Gan, W. J., Wark, P. A. B., Chung, K. F., Hughes, J. M., Armour, C. L., & Phipps, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01984.x · Cited by 100
Is RAGE Still A Therapeutic Target For Alzheimer’s Disease?
Deane, R. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.51 · Cited by 97
The S100B/RAGE Axis in Alzheimer's Disease
Leclerc, E., Sturchler, E., & Vetter, S. W. (2010) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2010/539581 · Cited by 97
Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors
Kim, H. J., Jeong, M. S., & Jang, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136904 · Cited by 99
Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice
Manigrasso, M. B., Rabbani, P. S., Egaña-Gorroño, L., Quadri, N., Frye, L., Zhou, B., Reverdatto, S., Ramirez, L. S., Dansereau, S. J., Pan, J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7084 · Cited by 91
Self-citation
S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis
Barateiro, A. P., Afonso, V., Santos, G., Cerqueira, J., Brites, D. M. T. O., van Horssen, J., & Fernandes, A. M. A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9336-6 · Cited by 92
The receptor for advanced glycation end-products: A complex signaling scenario for a promiscuous receptor
Armando Rojas, R., Delgado‐López, F., González, I., Pérez-Castro, R., Romero, J. A., & Rojas, I. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.11.022 · Cited by 86
The effects of advanced glycation end‐products on skin and potential anti‐glycation strategies
Wang, L., Jiang, Y., & Zhao, C. (2024) · Experimental Dermatology · doi:10.1111/exd.15065 · Cited by 97
Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products
Yatime, L., & Andersen, G. R. (2013) · FEBS Journal · doi:10.1111/febs.12556 · Cited by 90
Stable RAGE-Heparan Sulfate Complexes Are Essential for Signal Transduction
Xu, D., Young, J. H.-W., Krahn, J. M., Song, D., Corbett, K. D., Chazin, W., Pedersen, L. C., & Esko, J. D. (2013) · ACS Chemical Biology · doi:10.1021/cb4001553 · Cited by 85
Dietary advanced glycation endproducts (AGEs) increase their concentration in plasma and tissues, result in inflammation and modulate gut microbial composition in mice; evidence for reversibility
van Dongen, K. C. W., Linkens, A. M. A., Wetzels, S., Wouters, K., Vanmierlo, T., van de Waarenburg, M. P. H., Scheijen, J. L. J. M., de Vos, W. M., Belzer, C., & Schalkwijk, C. G. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110547 · Cited by 87
The importance of Ca2 Zn2 signaling S100 proteins and RAGE in translational medicine
Leclerc, E. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/223 · Cited by 78
Novel Sulfated Polysaccharides Disrupt Cathelicidins, Inhibit RAGE and Reduce Cutaneous Inflammation in a Mouse Model of Rosacea
Zhang, J., Xu, X., Rao, N. V., Argyle, B., McCoard, L., Rusho, W. J., Kennedy, T. P., Prestwich, G. D., & Krueger, G. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016658 · Cited by 73
RAGE signaling by alveolar macrophages influences tobacco smoke-induced inflammation
Robinson, A. B., Johnson, K. D., Bennion, B. G., & Reynolds, P. R. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00099.2012 · Cited by 78
Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress.
Younessi, P., & Yoonessi, A. (2011) · Europe PMC (PubMed Central) · Cited by 72
The Receptor for Advanced Glycation End Products (RAGE) and DIAPH1: Implications for vascular and neuroinflammatory dysfunction in disorders of the central nervous system
MacLean, M., Derk, J., Ruiz, H. H., Juranek, J. K., Ramasamy, R., & Schmidt, A. M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.012 · Cited by 69
S100B protein regulates myoblast proliferation and differentiation by activating FGFR1 in a bFGF-dependent manner
Riuzzi, F., Sorci, G., & Donato, R. (2011) · Journal of Cell Science · doi:10.1242/jcs.084491 · Cited by 70
Carboxylated N‐glycans on RAGE promote S100A12 binding and signaling
Srikrishna, G., Nayak, J., Weigle, B., Temme, A., Foell, D., Hazelwood, L., Olsson, A., Volkmann, N., Hanein, D., & Freeze, H. H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22575 · Cited by 72
Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling
Xue, J., Manigrasso, M. B., Scalabrin, M., Rai, V., Reverdatto, S., Burz, D. S., Fabris, D., Schmidt, A. M., & Shekhtman, A. G. (2016) · Structure · doi:10.1016/j.str.2016.06.021 · Cited by 66
Self-citation
Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development
Azizian-Farsani, F., Abedpoor, N., Sheikhha, M. H., Gure, A. O., Nasr‐Esfahani, M. H., & Ghaedi, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.552283 · Cited by 61
Structural Insights into Calcium-Bound S100P and the V Domain of the RAGE Complex
Penumutchu, S. R., Chou, R., & Yu, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103947 · Cited by 62
Differences in kinetics and dynamics of endogenous versus exogenous advanced glycation end products (AGEs) and their precursors
van Dongen, K. C. W., Kappetein, L., Estruch, I. M., Belzer, C., Beekmann, K., & Rietjens, I. M. C. M. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112987 · Cited by 63
S100B Engages RAGE or bFGF/FGFR1 in Myoblasts Depending on Its Own Concentration and Myoblast Density. Implications for Muscle Regeneration
Riuzzi, F., Sorci, G., Beccafico, S., & Donato, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028700 · Cited by 60
Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors
Singh, H., & Agrawal, D. K. (2022) · Drug Development Research · doi:10.1002/ddr.21971 · Cited by 57
The immunobiology of the receptor of advanced glycation end-products: Trends and challenges
González, I., Romero, J. A., Rodríguez, B. L., Pérez-Castro, R., & Armando Rojas, R. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.09.005 · Cited by 59
Amyloid Beta 25–35 induces blood-brain barrier disruption in vitro
Cuevas, E., Rosas-Hernández, H., Burks, S. M., Ramirez-Lee, M. A., Guzmán, A., Imam, S. Z., Ali, S. F., & Sarkar, S. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00447-8 · Cited by 58
The G82S Polymorphism Promotes Glycosylation of the Receptor for Advanced Glycation End Products (RAGE) at Asparagine 81
Park, S. J., Kleffmann, T., & Hessian, P. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.241281 · Cited by 55
The relationship between receptor for advanced glycation end products expression and the severity of periodontal disease in the gingiva of diabetic and non diabetic periodontitis patients
Abbass, M. M. S., Korany, N. S., Salama, A., Dmytryk, J. J., & Safiejko‐Mroczka, B. (2012) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2012.06.007 · Cited by 54
AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD?
Koyama, H., & Nishizawà, Y. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02298.x · Cited by 53
Diabetes and cancer: Looking at the multiligand/RAGE axis
Armando Rojas, R. (2011) · World Journal of Diabetes · doi:10.4239/wjd.v2.i7.108 · Cited by 52
Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease
Hobbs, B. D., Parker, M. M., Chen, H., Lao, T., Hardin, M. E., Qiao, D., Hawryłkiewicz, I., Śliwiński, P., Yim, J., Kim, W. J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2053oc · Cited by 53
The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins
Yatime, L., Betzer, C., Jensen, R. K., Mortensen, S., Jensen, P. H., & Andersen, G. R. (2016) · Structure · doi:10.1016/j.str.2016.09.011 · Cited by 50
The Immune Tolerance Role of the HMGB1-RAGE Axis
Watanabe, H., & Son, M. (2021) · Cells · doi:10.3390/cells10030564 · Cited by 51
RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer
Magna, M., Hwang, G. H., McIntosh, A. T., Drews‐Elger, K., Takabatake, M., Ikeda, A., Mera, B. J., Kwak, T., Miller, P., Lippman, M. E., et al. (2023) · npj Breast Cancer · doi:10.1038/s41523-023-00564-9 · Cited by 48
Role of the advanced glycation end products receptor in Crohn’s disease inflammation
Ciccocioppo, R. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i45.8269 · Cited by 47
Formula‐derived advanced glycation end products are involved in the development of long‐term inflammation and oxidative stress in kidney of IUGR piglets
Elmhiri, G., Mahmood, D. F. D., Niquet‐Léridon, C., Jacolot, P., Firmin, S., Guigand, L., Tessier, F. J., Larcher, T., & Abdennebi‐Najar, L. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400722 · Cited by 44
Disulfide Bonds within the C2 Domain of RAGE Play Key Roles in Its Dimerization and Biogenesis
Wei, W., Lampe, L., Park, S., Vangara, B. S., Waldo, G. S., Cabantous, S., Subaran, S. S., Yang, D., Lakatta, E. G., & Li, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050736 · Cited by 47
The clinical significance of circulating soluble RAGE in patients with severe sepsis
Matsumoto, H., Matsumoto, N., Ogura, H., Shimazaki, J., Yamakawa, K., Yamamoto, K., & Shimazu, T. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000651 · Cited by 42
Targeting the AGEs-RAGE axis: pathogenic mechanisms and therapeutic interventions in diabetic wound healing
Lin, H., Yang, Y., Wang, X., Chung, M., Zhang, L., Cai, S., Pan, X., & Pan, Y. C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1667620 · Cited by 49
Solution Structure of the Soluble Receptor for Advanced Glycation End Products (sRAGE)
Sárkány, Z., Ikonen, T. P., Ferreira‐da‐Silva, F., Saraiva, M. J., Svergun, D. I., & Damas, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223438 · Cited by 40
Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?
Marinakis, E., Bagkos, G., Piperi, C., Roussou, P. A., & Diamanti‐Kandarakis, E. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0578 · Cited by 41
The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
Sernoskie, S. C., Jee, A., & Uetrecht, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000090 · Cited by 41
The self‐association of HMGB 1 and its possible role in the binding to DNA and cell membrane receptors
Anggayasti, W. L., Mancera, R. L., Bottomley, S., & Helmerhorst, E. (2016) · FEBS Letters · doi:10.1002/1873-3468.12545 · Cited by 39
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions
Koerich, S., Parreira, G. M., de Almeida, D. L., Vieira, R. P., & de Oliveira, A. C. P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220922153903 · Cited by 40
Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA-AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models
Jandial, R., Neman, J., Lim, P. P., Tamae, D., Kowolik, C. M., Wuenschell, G. E., Shuck, S. C., Ciminera, A. K., Jesus, L. D., Ouyang, C., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020406 · Cited by 38

Authors: Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., & Shekhtman, A.
Affiliations: State University of New York (US)
Leipzig University (DE)
Corresponding author: Shekhtman, Alexander
ORCID: Xie, Jingjing
Reverdatto, Sergey
Frolov, Andrej
Hoffmann, Ralf
Shekhtman, Alexander
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2008-10
Volume: 283
Issue: 40
Pages: 27255-27269
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m801622200
OpenAlex: W2038792388
Cited by: 252
References: 81
Citations by year: 2026: 6 · 2025: 12 · 2024: 11 · 2023: 15 · 2022: 16 · 2021: 13 · 2020: 14 · 2019: 15 · 2018: 10 · 2017: 8 · 2016: 15 · 2015: 13 · 2014: 13 · 2013: 22 · 2012: 17
FWCI: 11.52
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 4397 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: American Diabetes Association
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords: receptor for advanced glycation end products, RAGE, advanced glycation end products, pattern recognition receptors, protein-protein interaction surfaces, plasma membrane, binding affinity, diabetes complications, neurodegenerative diseases, inflammation
MeSH terms: Receptor for Advanced Glycation End Products, Cell Line, Humans, Inflammation, Magnetic Resonance Spectroscopy, Protein Binding, Structure-Activity Relationship, Glycation End Products, Advanced, Protein Structure, Secondary, Protein Structure, Tertiary, Neurodegenerative Diseases, Protein Structure, Quaternary, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks